|
Volumn 62, Issue 18, 2013, Pages 1725-1726
|
Dipyrone (Metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease
|
Author keywords
aspirin; coronary artery disease; dipyrone; high treatment platelet reactivity; metamizole; nonresponder
|
Indexed keywords
ACETYLSALICYLIC ACID;
DIPYRONE;
THROMBOXANE;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG INHIBITION;
HUMAN;
LETTER;
LOW DRUG DOSE;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
THROMBOCYTE AGGREGATION INHIBITION;
ASPIRIN;
CORONARY ARTERY DISEASE;
DIPYRONE;
HIGH TREATMENT-PLATELET REACTIVITY;
METAMIZOLE;
NONRESPONDER;
AGED;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ASPIRIN;
CORONARY ARTERY DISEASE;
DIPYRONE;
DRUG INTERACTIONS;
HUMANS;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
THROMBOXANES;
|
EID: 84886389759
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2013.07.039 Document Type: Letter |
Times cited : (43)
|
References (4)
|